Gender differences in clinical outcomes among diabetic patients hospitalized for cardiovascular disease

American Heart Journal

Volumn 165, Issue 6, 2013, Pages 972-978

  Flink, Laura ^a   Mochari Greenberger, Heidi ^a   Mosca, Lori ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL EVALUATION; DIABETIC PATIENT; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; ETHNIC GROUP; FEMALE; GLYCEMIC CONTROL; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE;

EID: 84880081986     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.02.024     Document Type: Article

References (35)

1. Vaccarino V, Krumholz HM, Berkman LF, et al. Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women? Circulation 1995;91(6):1861-71.
2. Berger JS, Elliott L, Gallup D, et al. Sex differences in mortality following acute coronary syndromes. JAMA 2009;302(8):874-82.
3. Hochman JS, Tamis JE, Thompson TD, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med 1999;341(4):226-32.
4. Ahmed WA, Tully PJ, Knight JL, et al. Female sex as an independent predictor of morbidity and survival after isolated coronary artery bypass grafting. Ann Thorac Surg 2011;92(1):59-67.
5. Kim C, Redberg RF, Pavlic T, et al. A systematic review of gender differences in mortality after coronary artery bypass graft surgery and percutaneous coronary interventions. Clin Cardiol 2007;30(10): 491-5.
6. D'Ascenzo F, Gonella A, Quadri G, et al. Comparison of mortality rates in women versus men presenting with ST-segment elevation myocardial infarction. Am J Cardiol 2011;107(5):651-4.
7. Ogita M, Miyauchi K, Dohi T, et al. Gender-based outcomes among patients with diabetes mellitus after percutaneous coronary intervention in the drug-eluting stent era. Int Heart J 2011;52(6): 348-52.
8. Onuma Y, Kukreja N, Daemen J, et al. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: Insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries. JACC Cardiovasc Interv 2009;2(7):603-10.
9. Saxena A, Poh CL, Dinh DT, et al. Does patient gender affect outcomes after concomitant coronary artery bypass graft and aortic valve replacement? An Australian Society of Cardiac and Thoracic Surgeons Database study. Cardiology 2011;119(2):116-23.
10. Ueda H, Mitsusada N, Harimoto K, et al. Glycosylated hemoglobin is a predictor of major adverse cardiac events after drug-eluting stent implantation in patients with diabetes mellitus. Cardiology 2010; 116(1):51-7.
11. Corpus RA, George PB, House JA, et al. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 2004;43(1):8-14.
12. Chan CY, Li R, Chan JY, et al. The value of admission HbA(1c) level in diabetic patients with acute coronary syndrome. Clin Cardiol 2011; 34(8):507-12.
13. Tsuruta R, Miyauchi K, Yamamoto T, et al. Effect of preoperative hemoglobin A1c levels on long-term outcomes for diabetic patients after off-pump coronary artery bypass grafting. J Cardiol 2011;57(2):181-6.
14. Lemesle G, Bonello L, de Labriolle A, et al. Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantation. Am J Cardiol 2009;104(1):41-5.
15. Barrett-Connor EL, Cohn BA, Wingard DL, et al. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991; 265(5):627-31.
16. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: Meta-analysis of 37 prospective cohort studies. BMJ 2006;332(7533):73-8.
17. Medicare program; hospital inpatient value-based purchasing program. Final rule. Fed Regist 2011;76(88):26490-547.
18. Kocher RP, Adashi EY. Hospital readmissions and the Affordable Care Act: Paying for coordinated quality care. JAMA2011;306(16):1794-5.
19. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and FY 2012 rates; hospitals' FTE resident caps for graduate medical education payment. Final rules. Fed Regist 2011; 76(160):51476-846.
20. Mosca L, Mochari-Greenberger H, Aggarwal B, et al. Patterns of caregiving among patients hospitalized with cardiovascular disease. J Cardiovasc Nurs 2011;26(4):305-11.
21. Mosca L, Aggarwal B, Mochari-Greenberger H, et al. Association between having a caregiver and clinical outcomes 1 year after hospitalization for cardiovascular disease. Am J Cardiol 2012; 109(1):135-9.
22. Ghali WA, Hall RE, Ash AS, et al. Evaluation of complication rates after coronary artery bypass surgery using administrative data. Methods Inf Med 1998;37(2):192-200.
23. Ghali WA, Hall RE, Rosen AK, et al. Searching for an improved clinical comorbidity index for use with ICD-9-CM administrative data. J Clin Epidemiol 1996;49(3):273-8.
24. Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 2000;29(5):891-8.
25. Mochari-Greenberger HMM, Aggarwal B, Umann T, Mosca L. Caregiver status. A simple marker to identify cardiac surgery patients at risk for longer postoperative length of stay, rehospitalization, or death. J Cardiac Nurs 2012 [In Press].
26. Hammond G, Mochari-Greenberger H, Liao M, et al. Effect of gender, caregiver, on cholesterol control and statin use for secondary prevention among hospitalized patients with coronary heart disease. Am J Cardiol 2012;110(11):1613-8.
27. Howard BV, Cowan LD, Go O, et al. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care 1998;21(8):1258-65.
28. Hunt KJ, Williams K, Hazuda HP, et al. The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: The San Antonio Heart Study. Ann Epidemiol 2007;17(11): 870-7.
29. Chan P, Pan WH. Coagulation activation in type 2 diabetes mellitus: The higher coronary risk of female diabetic patients. Diabet Med 1995;12(6):504-7.
30. Steinberg HO, Paradisi G, Cronin J, et al. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation 2000;101(17):2040-6.
31. Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43(6):521-30.
32. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358(24):2545-59.
33. Gerstein HC, Miller ME, Genuth S, et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 2011; 364(9):818-28.
34. Aggarwal V, Schneider AL, Selvin E. Low hemoglobin A1c in nondiabetic adults: An elevated risk state? Diabetes Care 2012; 35(10):2055-60.
35. Adler NE, Adashi EY, Aguilar-Gaxiola S, et al. Institute of Medicine's (IOM) Committee on Women's Health Research. Women's health research: Progress, pitfalls, and promise. Washington DC: The National Academies Press; 2010.